Overview
COVID-19 treatment encompasses the pharmacological and supportive interventions used to manage infection with SARS-CoV-2, the betacoronavirus that emerged in late 2019 and joined SARS-CoV and MERS-CoV as agents capable of causing severe respiratory disease. Management is stratified by disease severity and phase: supportive and symptomatic care for mild illness, and for moderate-to-severe disease the addition of oxygen therapy, antiviral and immunomodulatory agents, anticoagulation, and organ support. Because severe disease reflects both viral replication and a dysregulated host inflammatory response, treatment strategy depends on timing, with antiviral approaches most relevant early and anti-inflammatory measures during the later hyperinflammatory phase. During the pandemic, repurposed drugs including hydroxychloroquine and chloroquine regimens were evaluated for clinical improvement, mortality, and viral kinetics, alongside interferon-based immunomodulation and cell therapy for the consequences of infection; laboratory markers such as white-cell and lymphocyte dynamics were studied to monitor response. Complications including secondary infections and vaccine-associated reactions also inform clinical decisions. Research published in this area examines therapeutic candidates, their mechanisms and measured outcomes, and the clinical course of infection, reflecting the journal's focus on the treatment of coronavirus disease.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
The Dynamic Changes of White Blood Cell Count and Lymphocyte Count and Compare their Levels in the Early Stage of Covid-19
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
COVID-19 and New Forms of Acute Pneumonia. It's Time for A Brainstorming Session
COVID-19 Pandemic: The Causative Agent is New, The Problem is Old
The Effect of Covid-19 Pandemic on Surgical Practice in Nigeria
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Mucormycosis: A Surge in Mucorales Fungal Infection in Post – Covid Patients in Indian States and Insight into Known and Unknown Factors
How this research is being cited
The 12 articles above have been cited 42 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Cereal Research Communications
-
2026 · South African Journal of Botany
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2024 · Expert Review of Molecular Diagnostics
-
2024 · ACS Omega
-
2024 · Frontiers in Microbiology
-
2024 · European Journal of Medical Research
A sample of recent works citing this journal's research on Covid and Treatment, linking to each citing work.